JUL 20, 2022 8:00 AM PDT

Detection of SARS-CoV-2 antibodies using an innovative approach: dried blood spots offer the possibility of home-based self-collection

Sponsored by: DiaSorin

Abstract
Date:  July 20, 2022
Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST)
 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be an international public health emergency due to rapid human-to-human transmission, emergence of new variants, high prevalence of asymptomatic carriers, and reduction of social distancing measures. While vaccination establishes protection through a combination of cell-mediated immunity and production of neutralizing antibodies, the longevity of circulating antibody against SARS-CoV-2 is relatively short, and the level of antibody needed to establish protection cutoffs has not yet been determined. Despite this, antibody levels continue to be used as the surrogate marker for exposure to SARS-CoV-2 through both vaccination and natural infection, and have successfully been used to inform public health responses. Serological measurements are typically performed using serum or plasma samples obtained intravenously; however, dried blood spot (DBS) samples offer an innovative approach of sample collection with several advantages over traditional phlebotomy. In addition to utilizing a smaller volume of blood (~75 µL of blood/spot) and less stringent shipping requirements, DBS cards can be successfully collected in point of care settings with minimal training. Here we describe the ability to measure SARS-CoV-2 antibodies from DBS samples using the LIAISON SARS-CoV-2 TrimericS IgG immunoassay, for measurement of antibodies in whole blood compared to traditional venous serum and plasma samples. The feasibility of using this assay to measure SARS-CoV-2 antibodies has been demonstrated in many international publications, however, further investigation including studies based on regulatory guidance is required prior to utilization of DBS samples for at-home self-collection.
 
Learning Objectives
  • To assess measurement of anti SARS-CoV-2 antibodies using the dry blood spot sampling
  • To evaluate the dry blood spot (DBS) sampling used in a routine setting
  • To demonstrate how DBS is able to facilitate the patient's life
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 

Show Resources
You May Also Like
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
Loading Comments...
Show Resources